Detalhe da pesquisa
1.
Phospho-tau with subthreshold tau-PET predicts increased tau accumulation rates in amyloid-positive individuals.
Brain
; 146(4): 1580-1591, 2023 04 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-36084009
2.
[18F]RO948 tau positron emission tomography in genetic and sporadic frontotemporal dementia syndromes.
Eur J Nucl Med Mol Imaging
; 50(5): 1371-1383, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36513817
3.
Robustness of CSF Aß42/40 and Aß42/P-tau181 measured using fully automated immunoassays to detect AD-related outcomes.
Alzheimers Dement
; 19(7): 2994-3004, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-36681387
4.
Tau-PET is superior to phospho-tau when predicting cognitive decline in symptomatic AD patients.
Alzheimers Dement
; 19(6): 2497-2507, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36516028
5.
Detecting amyloid positivity in early Alzheimer's disease using combinations of plasma Aß42/Aß40 and p-tau.
Alzheimers Dement
; 18(2): 283-293, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34151519
6.
Current advances in plasma and cerebrospinal fluid biomarkers in Alzheimer's disease.
Curr Opin Neurol
; 34(2): 266-274, 2021 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33470669
7.
Heterogeneous distribution of tau pathology in the behavioural variant of Alzheimer's disease.
J Neurol Neurosurg Psychiatry
; 2021 Apr 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-33850001
8.
A multicenter comparison of [18F]flortaucipir, [18F]RO948, and [18F]MK6240 tau PET tracers to detect a common target ROI for differential diagnosis.
Eur J Nucl Med Mol Imaging
; 48(7): 2295-2305, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34041562
9.
The strategic biomarker roadmap for the validation of Alzheimer's diagnostic biomarkers: methodological update.
Eur J Nucl Med Mol Imaging
; 48(7): 2070-2085, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33688996
10.
The impact of demographic, clinical, genetic, and imaging variables on tau PET status.
Eur J Nucl Med Mol Imaging
; 48(7): 2245-2258, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33215319
11.
Plasma Phospho-Tau Identifies Alzheimer's Co-Pathology in Patients with Lewy Body Disease.
Mov Disord
; 36(3): 767-771, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33285015
12.
The accumulation rate of tau aggregates is higher in females and younger amyloid-positive subjects.
Brain
; 143(12): 3805-3815, 2020 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33439987
13.
Stage-specific links between plasma neurofilament light and imaging biomarkers of Alzheimer's disease.
Brain
; 143(12): 3793-3804, 2020 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33210117
14.
The diagnostic and prognostic capabilities of plasma biomarkers in Alzheimer's disease.
Alzheimers Dement
; 17(7): 1145-1156, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33491853
15.
Compensating for choroid plexus based off-target signal in the hippocampus using 18F-flortaucipir PET.
Neuroimage
; 221: 117193, 2020 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32711062
16.
Head-to-head comparison of tau positron emission tomography tracers [18F]flortaucipir and [18F]RO948.
Eur J Nucl Med Mol Imaging
; 47(2): 342-354, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31612245
17.
Tau PET imaging in neurodegenerative tauopathies-still a challenge.
Mol Psychiatry
; 24(8): 1112-1134, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-30635637
18.
Synaptic vesicle protein 2A as a potential biomarker in synaptopathies.
Mol Cell Neurosci
; 97: 34-42, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30796959
19.
Discriminative Accuracy of Plasma Phospho-tau217 for Alzheimer Disease vs Other Neurodegenerative Disorders.
JAMA
; 324(8): 772-781, 2020 08 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-32722745
20.
Clinical impact of [18F]flutemetamol PET among memory clinic patients with an unclear diagnosis.
Eur J Nucl Med Mol Imaging
; 46(6): 1276-1286, 2019 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-30915522